首页> 美国卫生研究院文献>MedChemComm >Bioisosteric replacement of central 124-oxadiazole ring of high affinity CB2 ligands by regioisomeric 134-oxadiazole ring
【2h】

Bioisosteric replacement of central 124-oxadiazole ring of high affinity CB2 ligands by regioisomeric 134-oxadiazole ring

机译:区域异构的134-恶二唑环对高亲和力CB2配体的中心124-恶二唑环的生物立体取代

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has been reported that bioisosteric replacement of an 1,2,4-oxadiazole ring by an 1,3,4-oxadiazole ring leads to higher polarity, reduced metabolic degradation by human liver microsomes and reduced interaction with hERG channels. In a seven to eight step synthesis 1,3,4-oxadiazles >9a–c were synthesized as bioisosteric analogs of high-affinity but rather lipophilic CB2 ligands >1a–c containing an 1,2,4-oxadiazole ring. The 1,3,4-oxadiazole derivatives >9a and >9b show 10- and 50-fold reduced CB2 affinity compared to the 1,2,4-oxadiazole derivatives >1a and >1b, respectively. However, the 1,3,4-oxadiazole >9a has high CB2 affinity (Ki = 25 nM) and high selectivity over the CB1 receptor.
机译:据报道,用1,3,4-恶二唑环生物等位取代1,2,4-恶二唑环可导致更高的极性,减少的人肝微粒体代谢降解以及减少与hERG通道的相互作用。在七到八步的合成过程中,合成了1,3,4-恶二唑> 9a–c 作为具有高亲和力但亲脂性CB2配体> 1a–c 的生物立体异构体,其中1,2,4-恶二唑环。 1,1,2,4-恶二唑衍生物> 9a 和> 9b 与1,1,2,4-恶二唑衍生物>相比,其CB2亲和力降低了10倍和50倍1a 和> 1b 。但是,1,3,4-恶二唑> 9a 具有较高的CB2亲和力(Ki = 25 nM)和对CB1受体的高选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号